These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4183483)

  • 1. Immunologic studies of autoimmune disease in NZB-NZW F1 mice. I. Binding of fluorescein-labeled antinucleoside antibodies in lesions of lupus-like nephritis.
    Seegal BC; Accinni L; Andres GA; Beiser SM; Christian CL; Erlanger BF; Hsu K
    J Exp Med; 1969 Aug; 130(2):203-16. PubMed ID: 4183483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.
    Andres GA; Accinni L; Beiser SM; Christian CL; Cinotti GA; Erlanger BF; Hsu KC; Seegal BC
    J Clin Invest; 1970 Nov; 49(11):2106-18. PubMed ID: 4097660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
    Kotzin BL; Palmer E
    J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.
    Hahn BH; Ebling FM
    J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotype restriction in murine lupus; high frequency of three public idiotypes on serum IgG in nephritic NZB/NZW F1 mice.
    Hahn BH; Ebling FM
    J Immunol; 1987 Apr; 138(7):2110-8. PubMed ID: 3559204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological studies concerning the nephritis of systemic lupus erythematosus.
    Koffler D; Schur PH; Kunkel HG
    J Exp Med; 1967 Oct; 126(4):607-24. PubMed ID: 4168098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
    Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
    J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
    Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
    Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.
    Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T
    Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.
    Zhang M; Yu G; Chan B; Pearson JT; Rathanaswami P; Delaney J; Ching Lim A; Babcook J; Hsu H; Gavin MA
    Arthritis Rheumatol; 2015 Oct; 67(10):2723-31. PubMed ID: 26097207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.